Literature DB >> 21698528

N-myristoyltransferase in the leukocytic development processes.

Sujeet Kumar1, Baljit Singh, Jonathan R Dimmock, Rajendra K Sharma.   

Abstract

The lipidic modification of proteins has recently been shown to be of immense importance, although many of the roles of these modifications remain as yet unidentified. One of such key modifications occurring on several proteins is the covalent addition of a 14-carbon long saturated fatty acid, a process termed myristoylation. Myristoylation can occur during both co-translational protein synthesis and posttranslationally, confers lipophilicity to protein molecules, and controls protein functions. The protein myristoylation process is catalyzed by the enzyme N-myristoyltransferase (NMT), which exists as two isoforms: NMT1 and NMT2. NMT1 is essential for growth and development, during which rapid cellular proliferation is required, in a variety of organisms. NMT1 is also reported to be elevated in many cancerous states, which also involve rapid cellular growth, albeit in an unwanted and uncontrolled manner. The delineation of myristoylation-dependent cellular functions is still in a state of infancy, and many of the roles of the myristoylated proteins remain to be established. The development of cells of the leukocytic lineage represents a phase of rapid growth and development, and we have observed that NMT1 plays a role in this process. The current review outlines the roles of NMT1 in the growth and differentiation of the cells of leukocytic origin. The described studies clearly demonstrate the roles of NMT1 in the regulation of the developmental processes of the leukocytes cells and provide a basis for further research with the aim of unraveling the roles of protein myristoylation in both cellular and physiological context.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21698528      PMCID: PMC3327710          DOI: 10.1007/s00441-011-1202-x

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  55 in total

Review 1.  Post-translational myristoylation: Fat matters in cellular life and death.

Authors:  Dale D O Martin; Erwan Beauchamp; Luc G Berthiaume
Journal:  Biochimie       Date:  2010-11-05       Impact factor: 4.079

2.  Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo.

Authors:  Sulochana S Bhandarkar; Jacqueline Bromberg; Carol Carrillo; Ponniah Selvakumar; Rajendra K Sharma; Betsy N Perry; Baskaran Govindarajan; Levi Fried; Allie Sohn; Kalpana Reddy; Jack L Arbiser
Journal:  Clin Cancer Res       Date:  2008-09-15       Impact factor: 12.531

Review 3.  Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: protein N-myristoyltransferase: a new approach to antifungal therapy.

Authors:  J A Sikorski; B Devadas; M E Zupec; S K Freeman; D L Brown; H F Lu; S Nagarajan; P P Mehta; A C Wade; N S Kishore; M L Bryant; D P Getman; C A McWherter; J I Gordon
Journal:  Biopolymers       Date:  1997       Impact factor: 2.505

4.  Identification of the NH2-terminal blocking group of calcineurin B as myristic acid.

Authors:  A Aitken; P Cohen; S Santikarn; D H Williams; A G Calder; A Smith; C B Klee
Journal:  FEBS Lett       Date:  1982-12-27       Impact factor: 4.124

5.  Drosophila embryos lacking N-myristoyltransferase have multiple developmental defects.

Authors:  M Ntwasa; S Aapies; D A Schiffmann; N J Gay
Journal:  Exp Cell Res       Date:  2001-01-15       Impact factor: 3.905

6.  N-myristoyltransferase inhibitors as new leads to treat sleeping sickness.

Authors:  Julie A Frearson; Stephen Brand; Stuart P McElroy; Laura A T Cleghorn; Ondrej Smid; Laste Stojanovski; Helen P Price; M Lucia S Guther; Leah S Torrie; David A Robinson; Irene Hallyburton; Chidochangu P Mpamhanga; James A Brannigan; Anthony J Wilkinson; Michael Hodgkinson; Raymond Hui; Wei Qiu; Olawale G Raimi; Daan M F van Aalten; Ruth Brenk; Ian H Gilbert; Kevin D Read; Alan H Fairlamb; Michael A J Ferguson; Deborah F Smith; Paul G Wyatt
Journal:  Nature       Date:  2010-04-01       Impact factor: 49.962

7.  Targeted gene replacement demonstrates that myristoyl-CoA: protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans.

Authors:  J K Lodge; E Jackson-Machelski; D L Toffaletti; J R Perfect; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

8.  Elevated N-myristoyl transferase activity is reversed by sodium orthovanadate in streptozotocin-induced diabetic rat.

Authors:  M J King; S Pugazhenthi; R L Khandelwal; R K Sharma
Journal:  Biochim Biophys Acta       Date:  1993-01-10

Review 9.  Antifungals targeted to protein modification: focus on protein N-myristoyltransferase.

Authors:  Nafsika H Georgopapadakou
Journal:  Expert Opin Investig Drugs       Date:  2002-08       Impact factor: 6.206

10.  Molecules incorporating a benzothiazole core scaffold inhibit the N-myristoyltransferase of Plasmodium falciparum.

Authors:  Paul W Bowyer; Ruwani S Gunaratne; Munira Grainger; Chrislaine Withers-Martinez; Sasala R Wickramsinghe; Edward W Tate; Robin J Leatherbarrow; Katherine A Brown; Anthony A Holder; Deborah F Smith
Journal:  Biochem J       Date:  2007-12-01       Impact factor: 3.857

View more
  3 in total

Review 1.  Acylation in trypanosomatids: an essential process and potential drug target.

Authors:  Amanda M Goldston; Aabha I Sharma; Kimberly S Paul; David M Engman
Journal:  Trends Parasitol       Date:  2014-06-19

2.  Inhibition of N-myristoyltransferase1 affects dengue virus replication.

Authors:  San Suwanmanee; Yuvadee Mahakhunkijcharoen; Sumate Ampawong; Pornsawan Leaungwutiwong; Dorothée Missé; Natthanej Luplertlop
Journal:  Microbiologyopen       Date:  2019-03-07       Impact factor: 3.139

3.  Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo.

Authors:  Elgilda Musi; Gary K Schwartz; Jae Hyuk Yoo; Shannon J Odelberg; Dean Y Li; Michael Y Bonner; Ponniah Selvakumar; Shikha Rao; Linda C Gilbert; Justin Elsey; Jack L Arbiser
Journal:  Oncotarget       Date:  2019-07-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.